Want to know more about the next grand occasion for international academic exchange? Here’s the chance! Jot down the details of the 4th Hong Kong International Oncology Symposium. This Symposium is sponsored by ACT Genomics, and co-organized by Hong Kong Lung Cancer Study Group and Society of Clinical Oncology. The supporting co-organizers include City University of Hong Kong, Hong Kong College of Radiologists,Hong Kong Adventist Hospital and Hong Kong Integrated Oncology Centre. The symposium will be held on November 3 and 4 at Auditorium, Hong Kong Adventist Hospital, Tsuen Wan and City University of Hong Kong respectively.
This academic symposium is an important cancer conference highlighting the advances with potential scientific and clinical developments to transform cancer management. Discussed areas will cover frontiers in oncology, cancer immunotherapies, urogenital cancer, lung cancer, precision radiotherapy and precision oncology. The most heated themes will be discussed by an army of distinguished surgeons and researchers worldwide in the field of oncology.
We are pleased to announce the editorial team of AME Publishing Company is going to attend this event and showcase our journals, e.g. Annals of Translational Medicine (ATM: https://atm.amegroups.org), Journal of Thoracic Disease (SCIE and PubMed-indexed, impact factor: 2.365, https://jtd.amegroups.com/), Translational Cancer Research (SCIE indexed, impact factor: 1.167, TCR: https://tcr.amegroups.com/).
There we will be honoured to meet old and new friends, conduct exclusive interviews with the world-renowned experts, and report eventful information to our fellow readers.
For more information about the symposium, please refer to the link below: https://www.ios.org.hk/index.html
